Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients-Reference-Cited by-同舟云学术

Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients

Published:2015-07-07 Issue:3 Volume:11 Page:337-345
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:The Clinical Respiratory Journal

Author:

Hu Yang¹,Wang Liu-Sheng¹,Jin Yue-Ping¹,Du Shan-Shan¹,Du Yu-Kui¹,He Xian¹,Weng Dong¹,Zhou Ying¹,Li Qiu-Hong¹,Shen Li¹,Zhang Fen¹,Su Yi-Liang¹,Sun Xiao-Li¹,Ding Jing-Jing²,Zhang Wen-Hui³,Cai Hou-Rong²,Dai Hua-Ping³,Dai Jing-Hong²,Li Hui-Ping¹

Affiliation:

1. Department of Respiratory Medicine; Shanghai Pulmonary Hospital, The Affiliated Hospital of Tongji University, School of Medicine; Shanghai China

2. Department of Respiratory Medicine; Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School; Nanjing China

3. Department of Respiratory and Critical Care Medicine; The Affiliated Hospital of Beijing Chao-Yang Hospital, Capital Medical University; Beijing China

Funder

Fujirebio Inc.

Publisher

Wiley

Subject

Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/crj.12341/fullpdf

Reference35 articles.

1. The epidemiology of interstitial lung diseases;Coultas;Am J Respir Crit Care Med,1994

2. Epidemiology of interstitial lung diseases in Greece;Karakatsani;Respir Med,2009

3. Epidemiology and distribution of interstitial lung diseases in Turkey;Musellim;Clin Respir J,2014